Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Therapy||Indication/Tumor Type||Response Type||Profile Response Detail|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT02637687||Phase I||Larotrectinib||A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children (SCOUT)||Active, not recruiting||USA | ITA | GBR | FRA | ESP | DEU | CAN | AUS||13|
|NCT03215511||Phase Ib/II||Selitrectinib||A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer||Completed||USA | ITA | FRA | ESP | DEU | BEL | AUS||3|